Taisho Pharmaceutical

Phone: +81 81339852020

Web: https://www.taisho.co.jp

Native name	大正製薬ホールディングス株式会社
Romanized name	Taishō Seiyaku Hōrudingusu kabushiki gaisha
Type	Public KK
Traded as	TYO: 4581
ISIN
Industry	Pharmaceuticals
Founded	October 12, 1912 (1912-10-12)
Headquarters	Toshima-ku, Tokyo 170-8655, Japan
Area served	Worldwide
Key people	Akira Uehara (President CEO)
Products	Over-the-counter drugs Prescription drugs Energy drinks
Revenue	JPY 280 billion (FY 2017) (US$ 2.6 billion) (FY 20177)
Net income	JPY 31.6 billion (FY 2017) (US$ 298 million) (FY 2017)
Owner	Uehara family (33.52%)
Number of employees	6,340 (consolidated, as of March 31, 2018)
Website	www.taisho.co.jp

With over a century of history, Taisho Pharmaceutical Holdings has the largest share of Japan’s over-the-counter pharmaceutical market and a strong presence in health food, cosmetics, and other fields. The Company's mission is to contribute to society by creating and offering superior pharmaceuticals and health-related products as well as healthcare-related information and services in socially responsible ways that enrich people's lives by improving health and beauty.

For detailed contact information visit location pages below.